INID Research Lab

INID Research Lab is a nutraceutical company focused on commercializing Glyteine, its branded form of gamma-glutamylcysteine, as a dietary supplement ingredient intended to raise cellular glutathione levels. The company markets commercial consumer products under the Continual-G brand, offered in capsule and beverage powder formats. Its origin story is tied to research led by Dr. Wallace Bridge and Martin Zarka, who developed and patented a gamma-glutamylcysteine manufacturing process that was licensed for commercialization. INID positions itself as a science-backed wellness company working with researchers, medical practitioners, contract formulators, and distributors rather than as a traditional drug-development biotech. Based on the available public information, its business is centered on nutraceutical commercialization rather than a disclosed therapeutic drug pipeline.